908 Devices (MASS) EPS (Diluted) Growth (1y) (2021 - 2026)
908 Devices (MASS) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 114.19% |
| 10 | 908 Devices | 260.31 Mn | 148.57 Mn | 6.88 Mn | -126.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.76% |
| Dec 31, 2025 | 94.34% |
| Sep 30, 2025 | 98.78% |
| Jun 30, 2025 | 92.40% |
| Mar 31, 2025 | 1,083.66% |
| Dec 31, 2024 | 56.42% |
| Sep 30, 2024 | 25.72% |
| Jun 30, 2024 | 49.68% |
| Mar 31, 2024 | 60.84% |
| Dec 31, 2023 | 25.88% |
| Sep 30, 2023 | -10.73% |
| Jun 30, 2023 | -12.58% |
| Mar 31, 2023 | -14.58% |
| Dec 31, 2022 | -17.08% |
| Sep 30, 2022 | -5.82% |
| Jun 30, 2022 | 16.55% |
| Mar 31, 2022 | -53.20% |
| Dec 31, 2021 | 85.78% |
| Sep 30, 2021 | 39.73% |
| Jun 30, 2021 | -294.44% |